UroToday.com (@urotoday)
@urotoday
Largest global online community of #urological# medical professionals & patients. #bladdercancer# #menshealth# #prostatecancer# #kidneycancer# #Urology#
6K 正在关注 31.1K 粉丝
Rectal spacers in prostate radiotherapy: Balancing efficacy, safety, and patient experience. Michael Greenberg, MD @JeffersonUniv & @DanWelchons @AMPofNY join @zklaassen_md @GACancerCenter to discuss rectal spacing before #ProstateCancer# radiotherapy. They trace the product evolution from SpaceOAR's pegylated hydrogel to Barrigel®. #WatchNow# on UroToday > @Barrigel_spacer @teleflex
显示更多
Translational insights for cretostimogene grenadenorepvec for BCG-naïve #BladderCancer#. @tbivala1 @PennMedicine joins @UroDocAsh @UTMDAnderson to discuss the translational data from CORE-008 Cohort A, examining cretostimogene grenadenorepvec in high-risk BCG-naive NMIBC with a focus on the five-step versus two-step administration protocol. #WatchNow# >
显示更多
CORE-008 Cohort A evaluates cretostimogene in BCG‑naive high‑risk #NMIBC#. Shreyas Joshi, MD, MPH @WinshipAtEmory joins @urodocash @UTMDAnderson reviewing CORE-008 Cohort A, reporting early phase 2 results for cretostimogene grenadenorepvec in high-risk BCG-naive NMIBC. #WatchNow# > @cgoncology
显示更多
Retrospective cohort analysis of Blue-Light cystoscopy using a claims database. @MarkTysonMD @MayoClinic joins @UroDocAsh @UTMDAnderson reviewing a real-world cost analysis of blue-light versus white-light cystoscopy, drawing on a matched Optum database cohort. Dr. Tyson notes the PHOTO trial found similar recurrence-free survival with higher costs in predominantly intermediate-risk patients. #WatchNow# on UroToday >
显示更多
Genomic classifiers and AI for personalizing #ProstateCancer# radiation therapy. @drjefstathiou @MassGenBrigham joins @neerajaiims @huntsmancancer to discuss the use of genomic classifiers and AI-based tools in personalizing radiation therapy for prostate cancer. #WatchNow# on UroToday > #APCCC26# @Decipher_VCYT @APCCC_Lugano @arteraAI
显示更多
Investigation therapy studied for pathway for treating chronic bladder pain and aging-related issues. Lori Birder, PhD @PittHealthSci joins Alan Wein, MD, PhD(hon), FACS @dsui_miami_uro to discuss 8-aminoguanine (8-AG), a purine nucleoside phosphorylase inhibitor restoring balance between protective purines like inosine and uro-damaging purines. #WatchNow# >
显示更多
